Floatz logo

Plavix

Postoperative Pain

Hunter Holmes Mcguire Veteran Affairs Medical CenterN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

30 Active assets in the Postoperative Pain cohort.

Asset / SponsorPhaseRating
LIDOCAINE
Instituto Mexicano del Seguro Social
Phase 4BBB
ROPIVACAINE
Tianjin Medical University General Hospital
Phase 4BBB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Tanta University
Phase 4BBB
NEPENTHE
IVO JURISIC
Phase 4BBB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
The Second Affiliated Hospital of Chongqing Medical University
Phase 4BB

View all 50 →

Same molecule, other indications

Plavix is also rated in:

myocardial infarctionDormant
A
Indicative ·
81 / 100
View asset →
transient ischemic attackDormant
BBB
Indicative ·
77 / 100
View asset →
peripheral arterial diseaseDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →